Moleculin Biotech (MBRX) has received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing tumor-specific immunity against multiple cancer types ...

Fermenta Biotech Ltd share price was down by -2.82% from the previous closing price of ₹402.65. Who are peers of Fermenta Biotech Ltd? The peers of Fermenta Biotech Ltd are Sun Pharmaceuticals ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Moleculin Biotech (MBRX) has received first country regulatory approval in Europe to begin recruiting for its Phase 3 pivotal trial protocol ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

US-based pharmaceutical company Moleculin Biotech has received approval from Ukraine's Ministry of Health to begin enrolment in its Phase III trial of annamycin with cytarabine for treating acute ...

ShreeGanesh Bio Standalone September 2024 Net Sales at Rs 1.98 crore, down 51.82% Y-o-Y Oct 24 2024 11:46 AM ShreeGanesh Bio Standalone June 2024 Net Sales at Rs 3.56 crore, down 56.92% Y-o-Y Aug ...

Indrayani Biotech Ltd share price was down by -3.83% from the previous closing price of ₹34.20. Who are peers of Indrayani Biotech Ltd? The peers of Indrayani Biotech Ltd are 3M India Ltd ...